According to some of the recently conducted experiments, cannabis is considered to be an effective remedy for patients who have been diagnosed with multiple sclerosis. Although at first the symptomatic improvements that are experienced by the patients with MS who have been administered using cannabinoid products were considered to be determined exclusively by psychological factors, whereas research later revealed that the use of cannabis helps reduce muscular stiffness and spasms that the MS sufferers experience. The beneficial effects of cannabis of Multiple sclerosis patients have been proved by both short-term, as well as, long-term studies.
In the year 2003, a team of researchers from the Peninsula Medical School in Exeter, UK made public the results of an array of both short-term and long-term studies made on the effects of cannabis among the MS patients. The previously conducted studies comprised of active participation of almost 600 patients with advanced stage MS. The participants were divided into two different groups: the first one had cannabis compounds on equal doses, whereas the other group had placebo medications over the time of 15 weeks. As the experiment ended, most of the patients administered with cannabis experienced significant symptomatic improvements, less muscular pain and being confronted with milder muscular spasticity. Unlike the other group that was given cannabis compounds throughout the study period, the control group experienced no improvements in their condition at all.
To validate the relevance of the findings and to eradicate any doubts concerning the efficiency of cannabis in ameliorating the symptoms of MS, the experiment was later repeated. This ulterior experiment was performed over the period of 12 months and involved the participation of same subjects. However, the participants were divided into 3 different groups this time instead of 2. One group received the pills of D9-tetrahydrocannabinol (THC) – which is one of the active components in cannabis; other group has natural cannabis extracts, whereas the third group had placebo medications.
At the end of this experience, patients were carefully examined and evaluated by a team of neurologist sand physiotherapists. The best outcomes were obtained among patients belonging to the first group, as most of the subjects received equal doses of THC experiencing significant improvements in their symptoms. The patients from the second group had slight improvements, whereas patients from the third group felt no changes in their condition at all.
The study clearly states that the use of cannabis proves to be an effective remedy for MS, medical experts, however, are still not convinced that cannabis can be effectively used in the treatment of multiple sclerosis or not. However, research indicates that doctors are now considering introducing cannabis elements in the treatment of MS in the near future.